HomeCompareRENB vs DVY

RENB vs DVY: Dividend Comparison 2026

RENB yields 140.85% · DVY yields 3.50%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RENB wins by $18.20M in total portfolio value
10 years
RENB
RENB
● Live price
140.85%
Share price
$1.42
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.23M
Annual income
$7,605,007.88
Full RENB calculator →
DVY
DVY
● Live price
3.50%
Share price
$150.03
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$437.78
Full DVY calculator →

Portfolio growth — RENB vs DVY

📍 RENB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRENBDVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RENB + DVY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RENB pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RENB
Annual income on $10K today (after 15% tax)
$11,971.83/yr
After 10yr DRIP, annual income (after tax)
$6,464,256.70/yr
DVY
Annual income on $10K today (after 15% tax)
$297.17/yr
After 10yr DRIP, annual income (after tax)
$372.11/yr
At 15% tax rate, RENB beats the other by $6,463,884.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RENB + DVY for your $10,000?

RENB: 50%DVY: 50%
100% DVY50/50100% RENB
Portfolio after 10yr
$9.13M
Annual income
$3,802,722.83/yr
Blended yield
41.67%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RENB buys
0
DVY buys
0
No recent congressional trades found for RENB or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRENBDVY
Forward yield140.85%3.50%
Annual dividend / share$2.00$5.25
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$18.23M$25.1K
Annual income after 10y$7,605,007.88$437.78
Total dividends collected$16.79M$4.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RENB vs DVY ($10,000, DRIP)

YearRENB PortfolioRENB Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$24,785$14,084.51$11,050$349.62+$13.7KRENB
2$59,143$32,624.07$12,184$361.04+$47.0KRENB
3$136,042$72,758.05$13,409$372.07+$122.6KRENB
4$301,974$156,409.10$14,730$382.68+$287.2KRENB
5$647,582$324,470.73$16,154$392.89+$631.4KRENB
6$1,343,219$650,306.15$17,688$402.69+$1.33MRENB
7$2,697,870$1,260,625.08$19,338$412.07+$2.68MRENB
8$5,253,056$2,366,334.87$21,113$421.04+$5.23MRENB
9$9,926,863$4,306,093.23$23,020$429.61+$9.90MRENB
10$18,226,751$7,605,007.88$25,070$437.78+$18.20MRENB

RENB vs DVY: Complete Analysis 2026

RENBStock

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Full RENB Calculator →

DVYETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this RENB vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RENB vs SCHDRENB vs JEPIRENB vs ORENB vs KORENB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.